Pale Fire Capital Se Ocular Therapeutix, Inc Transaction History

Pale Fire Capital Se

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 13, 2025	BUY	$6.02 - $9.46 $546,302 - $858,476	90,748 Added 20.65%	530,135 $4.92 Billion
Q1 2025 May 14, 2025	SELL	$5.93 - $9.08 $32,176 - $49,268	-5,426 Reduced 1.22%	439,387 $3.22 Billion
Q4 2024 Feb 13, 2025	BUY	$8.33 - $11.47 $55,086 - $75,851	6,613 Added 1.51%	444,813 $3.8 Billion
Q3 2024 Nov 12, 2024	BUY	$6.45 - $9.23 $2.83 Million - $4.04 Million	438,200 New	438,200 $3.81 Billion

235

157M

1.24M

423K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $875M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

Stay updated on Pale Fire Capital Se with notifications on news.